Allarity Therapeutics Expands its Stenoparib License Rights to Include Anti-Viral Uses
Press Release Hørsholm, Denmark (14 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that...
News
Dr. Bobbi Peterson Overcomes Cancer, Bouncing Back With ThirstRX and a New YouTube Channel
Dr. Bobbi Peterson has not let being diagnosed with cancer hold her back. The celebrity doctor launches ThristRX and documents...
TG Therapeutics Announces Proposed Public Offering of Common Stock
NEW YORK, Dec. 14, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines...
Cytokinetics Announces Data and Trial Design Presented at the International Symposium on ALS/MND
Additional Data from FORTITUDE-ALS Support Rationale and Design for COURAGE-ALS, A Planned Phase 3 Clinical Trial of Reldesemtiv in Patients with...
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”)...
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors
SEATTLE, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing...
Cerevel Therapeutics to Host Inaugural Virtual R&D Event
Event will focus on CVL-865, the Phase 2 GABA Positive Allosteric Modulator, and include an overview of key preclinical programs...
Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO
PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the...
Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471 and ARV-110
– ARV-471 demonstrates evidence of anti-tumor activity, and potential for best-in-class safety, and estrogen receptor (ER) degradation profile and robust...
Iovance Biotherapeutics Appoints Jean-Marc Bellemin as Chief Financial Officer
SAN CARLOS, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel...
Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B
Updated dose-ranging data demonstrate potential for full normalization of FIX activity Long-term follow up data show durable FIX activity out...
SpectrumX announces launch of new high capacity SpectriPOD disinfection tunnels at Joshua v Pulev world title fight
LONDON, Dec. 14, 2020 (GLOBE NEWSWIRE) -- SpectrumX Healthcare Limited is delighted to announce the successful launch of new biosecurity...
Relay Therapeutics Announces a Worldwide License and Collaboration Agreement with Genentech for RLY-1971
Collaboration brings together clinical stage SHP2 and KRAS G12C inhibitors Relay Therapeutics will receive $75 million upfront and is eligible...
HEXO Corp announces results of its annual and special meeting of shareholders
OTTAWA, Dec. 14, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE:HEXO) is pleased to announce the results of...
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
Analysis of 37 participants immunized with BNT162b2 showed a broad immune response with SARS-CoV-2-specific neutralizing antibodies, TH1 type CD4+ T...
Amarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical Results
REDUCE-IT® EPA Encore Presentation reinforces Eicosapentaenoic Acid (EPA) levels from VASCEPA® (icosapent ethyl) strongly correlated to cardiovascular outcomes, more so...
Avricore Health Successfully Intergrates ID Now™ Rapid PCR Test Device, Offering Real-Time Covid-19 Reporting Direct From Instrument for First Time.
Earlier this fall, the Company announced a joint working agreement to integrate a major manufacturer’s devices with its HealthTab™ data...
Smiths Medical Announces Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio
Inspired Engineering for Enhanced Visualization MINNEAPOLIS--(BUSINESS WIRE)--#ourpassionyourlife--Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of...
Spectrum Pharmaceuticals Appoints Nora Brennan to Board of Directors
HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment...
Avaya Earns Frost & Sullivan Award for Excellence in Healthcare Solutions
Competitive Strategy Leadership Award Recognizes Avaya’s Extensive Portfolio and Overall Ability to Improve Patient Care and Engagement RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--Avaya...